Appili Therapeutics (APLIF) Short Interest Ratio & Short Volume $0.03 0.00 (0.00%) (As of 11/22/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartEarningsHeadlinesShort Interest Appili Therapeutics Short Interest DataAppili Therapeutics (APLIF) has a short interest of 7,800 shares. This marks a 310.53% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 98,485 shares to cover all short positions.Current Short Interest7,800 sharesPrevious Short Interest1,900 sharesChange Vs. Previous Month+310.53%Dollar Volume Sold Short$206.70Short Interest Ratio0.0 Days to CoverLast Record DateOctober 31, 2024Today's Trading Volume211 sharesAverage Trading Volume98,485 sharesToday's Volume Vs. Average0% Short Selling Appili Therapeutics? Sign up to receive the latest short interest report for Appili Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAPLIF Short Interest Over TimeAPLIF Days to Cover Over TimeAPLIF Percentage of Float Shorted Over Time Ad StockEarnings9 hidden AI stocks set to thrive in Trump’s new eraAI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be worth trillions of dollars (here’s how to tap into this new wealth)Get the Name of These AI Picks Now Appili Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20247,800 shares $206.70 +310.5%N/A0 $0.03 10/15/20241,900 shares $45.22 -99.0%N/A0 $0.02 9/30/2024198,900 shares $5,171.40 No ChangeN/A0.7 $0.03 8/31/20241,000 shares $29.10 -94.4%N/A0 $0.03 8/15/202417,800 shares $428.98 +2,866.7%N/A0.1 $0.02 7/31/2024600 shares $15.88 No ChangeN/A0 $0.03 Get the Latest News and Ratings for APLIF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Appili Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 6/15/202427,300 shares $839.75 -3.5%N/A0.4 $0.03 5/31/202428,300 shares $724.48 -28.4%N/A0.2 $0.03 5/15/202439,500 shares $1,027.00 +26.2%N/A0.3 $0.03 4/30/202431,300 shares $939.00 -16.3%N/A1 $0.03 4/15/202437,400 shares $942.48 -69.9%N/A0 $0.03 3/31/2024124,200 shares $2,657.88 +42.9%N/A7.2 $0.02 3/15/202486,900 shares $1,929.18 +16.5%N/A0.3 $0.02 2/29/202474,600 shares $1,618.82 +106.1%N/A0.1 $0.02 2/15/202436,200 shares $807.26 -5.0%N/A0.2 $0.02 1/15/202439,300 shares $884.25 -4.8%N/A0.1 $0.02 12/31/202341,300 shares $1,094.45 -2.1%N/A0.6 $0.03 12/15/202342,200 shares $1,055.00 -2.3%N/A1.3 $0.03 11/30/202343,200 shares $1,028.16 -47.4%N/A0.3 $0.02 11/15/202382,100 shares $1,814.41 +81.6%N/A1.1 $0.02 10/31/202345,200 shares $1,301.76 -35.8%N/A0.4 $0.03 10/15/202370,400 shares $2,112.00 +4.1%N/A0.2 $0.03 9/30/202367,600 shares $2,804.05 +37.4%N/A0 $0.04 9/15/202349,200 shares $1,968.00 No ChangeN/A0.3 $0.04 8/31/202349,200 shares $1,972.92 -53.7%N/A0.2 $0.04 8/15/2023106,200 shares $3,823.20 -33.8%N/A0.2 $0.04 7/31/2023160,400 shares $7,185.92 +226.0%N/A0.1 $0.04 7/15/202349,200 shares $1,520.28 -22.2%N/A0.1 $0.03 6/30/202363,200 shares $1,390.40 +14.5%N/A0.5 $0.02 6/15/202355,200 shares $1,269.60 +10.0%N/A2.7 $0.02 5/31/202350,200 shares $1,417.65 -3.3%N/A3.3 $0.03 5/15/202351,900 shares $1,385.73 +1.4%N/A0.8 $0.03 4/30/202351,200 shares $1,505.28 No ChangeN/A1 $0.03 4/15/202351,200 shares $1,315.84 No ChangeN/A13.8 $0.03 3/31/202351,200 shares $1,295.36 No ChangeN/A0.5 $0.03 3/15/202351,200 shares $1,720.32 -4.5%N/A7.9 $0.03 2/28/202353,600 shares $1,817.04 +4.7%N/A5.7 $0.03 2/15/202351,200 shares $4,096.00 -1.9%N/A0.9 $0.08 1/31/202352,200 shares $2,124.54 No ChangeN/A1.9 $0.04 1/15/202352,200 shares $2,453.40 -13.9%N/A3.5 $0.059 hidden AI stocks set to thrive in Trump’s new era (Ad)AI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be worth trillions of dollars (here’s how to tap into this new wealth)Get the Name of These AI Picks Now 12/30/202260,600 shares $2,187.66 -10.2%N/A0.7 $0.04 12/15/202267,500 shares $3,003.75 +12.1%N/A1.6 $0.04 11/30/202260,200 shares $2,100.98 -10.4%N/A7.3 $0.03 11/15/202267,200 shares $2,197.44 -6.9%N/A2.4 $0.03 10/31/202272,200 shares $3,046.84 -5.3%N/A14.7 $0.04 10/15/202276,200 shares $2,739.39 -1.3%N/A8.9 $0.04 9/30/202277,200 shares $3,010.80 -1.3%N/A0.9 $0.04 9/15/202278,200 shares $3,503.36 -33.2%N/A1.7 $0.04 8/31/2022117,100 shares $5,491.99 -17.0%N/A8.9 $0.05 8/15/2022141,100 shares $8,697.40 +7.1%N/A13.7 $0.06 7/31/2022131,700 shares $6,775.97 +24.6%N/A13.7 $0.05 7/15/2022105,700 shares $5,348.42 +16.4%N/A1.8 $0.05 6/30/202290,800 shares $5,284.56 No ChangeN/A2.4 $0.06 6/15/202290,800 shares $4,939.52 -44.3%N/A4.5 $0.05 5/31/2022162,900 shares $9,774.00 -0.8%N/A8.8 $0.06 5/15/2022164,200 shares $12,725.50 -16.8%N/A10.9 $0.08 4/30/2022197,400 shares $16,591.47 -14.0%N/A23.5 $0.08 4/15/2022229,400 shares $21,242.44 +1.1%N/A3.6 $0.09 3/31/2022226,900 shares $22,190.82 -3.5%N/A24.4 $0.10 3/15/2022235,100 shares $20,007.01 +9.4%N/A2.3 $0.09 2/28/2022214,900 shares $23,789.43 -8.9%N/A3 $0.11 2/15/2022235,900 shares $22,811.53 +2.3%N/A3.3 $0.10 1/31/2022230,700 shares $21,778.08 +61.0%N/A1.6 $0.09 1/15/2022143,300 shares $12,997.31 +34.2%N/A2 $0.09 12/31/2021106,800 shares $9,579.96 -53.2%N/A1.6 $0.09 12/15/2021228,000 shares $16,735.20 +2.6%N/A0.7 $0.07 11/30/2021222,200 shares $26,664.00 +14.8%N/A0.6 $0.12 11/15/2021193,600 shares $34,906.08 +15.2%N/A0.3 $0.18 10/29/2021168,000 shares $103,051.20 +313.8%N/A1.1 $0.61 10/15/202140,600 shares $23,978.36 -74.2%N/A0.3 $0.59 9/30/2021157,200 shares $135,034.80 +30.5%N/A1 $0.86 9/15/2021120,500 shares $90,965.45 +16.2%N/A1.1 $0.75 8/31/2021103,700 shares $64,605.10 +2.4%N/A1.4 $0.62 8/13/2021101,300 shares $56,728.00 +3.2%N/A1.4 $0.56 7/30/202198,200 shares $64,075.50 +2.2%N/A1.7 $0.65 7/15/202196,100 shares $48,050.00 +15.8%N/A2.7 $0.50 6/30/202183,000 shares $46,338.90 -6.2%N/A1.1 $0.56 6/15/202188,500 shares $54,117.75 +19.1%N/A0.5 $0.61 5/28/202174,500 shares $54,166.72 -8.3%N/A0.5 $0.73 5/14/202181,200 shares $71,610.28 +140.2%N/A0.6 $0.88 4/30/202133,800 shares $34,104.20 +84.7%N/A0.3 $1.01 4/15/202118,300 shares $14,656.47 -3.2%N/A0.2 $0.80 3/31/202118,900 shares $16,053.66 -2.6%N/A0.2 $0.85 3/15/202119,400 shares $16,206.76 +68.7%N/A0.5 $0.84 2/26/202111,500 shares $10,213.15 -62.8%N/A0.1 $0.89 2/12/202130,900 shares $33,372.00 +147.2%N/A0.2 $1.08 1/29/202112,500 shares $9,750.00 +197.6%N/A0.4 $0.78 1/15/202115,700 shares $13,721.80 +190.7%N/A0.2 $0.87 12/31/20204,600 shares $4,232.00 -70.7%N/A0.1 $0.92 12/15/202015,700 shares $16,328.00 +190.7%N/A0.2 $1.049 hidden AI stocks set to thrive in Trump’s new era (Ad)AI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be worth trillions of dollars (here’s how to tap into this new wealth)Get the Name of These AI Picks Now 11/30/20205,400 shares $5,319.00 -70.2%N/A0.1 $0.99 11/15/202018,100 shares $16,677.34 +805.0%N/A0.3 $0.92 10/30/20202,000 shares $2,040.00 -4.8%N/A0.1 $1.02 10/15/20202,100 shares $2,079.00 +23.5%N/A0.1 $0.99 APLIF Short Interest - Frequently Asked Questions What is Appili Therapeutics' current short interest? Short interest is the volume of Appili Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 7,800 shares of APLIF short. Learn More on Appili Therapeutics' current short interest. Is Appili Therapeutics' short interest increasing or decreasing? Appili Therapeutics saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 7,800 shares, an increase of 310.5% from the previous total of 1,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Appili Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Appili Therapeutics: Antibe Therapeutics Inc. (0.12%), Apollomics, Inc. (0.25%), BetterLife Pharma Inc. (0.02%), ImmunoPrecise Antibodies Ltd. (3.05%), Indaptus Therapeutics, Inc. (1.85%), Oncotelic Therapeutics, Inc. (0.00%), Imunon, Inc. (3.52%), Mustang Bio, Inc. (1.59%), Kiora Pharmaceuticals, Inc. (1.76%), Conduit Pharmaceuticals Inc. (3.47%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Appili Therapeutics stock? Short selling APLIF is an investing strategy that aims to generate trading profit from Appili Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Appili Therapeutics? A short squeeze for Appili Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of APLIF, which in turn drives the price of the stock up even further. How often is Appili Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APLIF, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies ATBPF Short Squeeze APLM Short Squeeze BETRF Short Squeeze IPA Short Squeeze INDP Short Squeeze OTLC Short Squeeze IMNN Short Squeeze MBIO Short Squeeze KPRX Short Squeeze CDT Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:APLIF) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersThe #1 ETF for monthly incomeWe just found the #1 ETF for monthly income. This outlier is paying a huge 22% dividend... And you could...Investors Alley | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Appili Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Appili Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.